CEO Seshadri Vishwas Offloads 19,608 ABEONA Shares Amid Week‑Long Stock Drop and Surge in Insider Selling
Insider selling at ABEONA THERAPEUTICS reveals tax‑driven sales amid a shaky biotech market; learn what this signals for investors and the company’s future.
3 minutes to read